Oct. 31, 2011
BIO-Europe 2011 - October 31–November 2, 2011, CCD Duesseldorf, Germany
We are pleased to inform you that NewBridge Pharmaceuticals will be present at this year’s BIO-Europe from October 31–November 2, 2011 at CCD Congress Center Duesseldorf, Germany. Our Executive Management from the UAE, Mr. Joe Henein, CEO & President of NewBridge Pharmaceuticals, Mr. Garrett Vygantas, MD, Vice President Strategy & Business Development from the USA, and Ms. Misan Abu Rmaileh, Business Development Manager will be available to meet with you to discuss potential business opportunities in the AfMET (Africa, Middle East and Turkey) region. For appointments, please contact Ms. Misan ...
Oct. 25, 2011
NewBridge Pharmaceuticals is attending the CPhI Worldwide 2011 from 25-27 October 2011 in Messe Frankfurt, Germany. Should you wish to meet with our Executive Management, CEO & President of NewBridge Pharmaceuticals, Mr. Joe Henein, Commercial Director Middle East, Mr. Alaa El Gamal, and Business Development Manager, Ms. Misan Abu Rmaileh to discuss potential business opportunities in AfMET (Africa, Middle East & Turkey) region, please contact us at firstname.lastname@example.org.
About NewBridge Pharmaceuticals
Based in Dubai, UAE, NewBridge is a specialty pharmaceutical, biologics, medical devices company serving the emerging markets of Africa, Middle East, Turkey, and Caspian regions (collectively, AfMET) to ...
Oct. 21, 2011
World Economic Forum Special Meeting on Economic Growth and Job Creation in the Arab World
In cooperation with King Abdullah Fund for Development (KAFD), Jordan is hosting this year's World Economic Forum (WEF) at the Dead Sea from October 21-23. The sixth WEF will focus on urgent economic and development challenges in the Arab region.
Mr. Joe Henein President & CEO of NewBridge Pharmaceuticals is participating in this special meeting, together among 700 Arab and International opinion leaders and world renowned experts and speakers in politics, economics, business, culture, education, technology and media, to discuss on how the business ...
May 5, 2011
The Fifth International Pharmaceuticals Regulatory & Compliance Congress and Best Practice Forum
May 3-5, 2011, Istanbul, Turkey
The Pharmaceutical Compliance Forum International Pharma Congress brings together senior global compliance and ethics professionals and legal counsel from the European Union (EU), Central and Eastern Europe (CEE) and Middle East and Africa (MEA) to share experiences and best practices to clarify these challenges and discuss potential responses to them.
The Congress was keynoted by David Brennan, Chief Executive Officer, AstraZeneca and President, International Federation of Pharmaceutical, Manufacturers and Associations (IFPMA).
Mr. Joe Henein, President and Chief Executive Officer of NewBridge Pharmaceuticals, former ...
April 7, 2011
BURRILL & COMPANY
Annual Limited Partners and Advisory Board Meeting
April 5-7, 2011, Montage Deer Valley, Park City, UT, U.S.A.
Burrill & Company’s Annual Limited Partners and Advisory Board meeting was held this year in Park City, UT from April 5-7, 2011. Mr. Joe Henein, CEO & President of NewBridge Pharmaceuticals was invited to attend and participate as a speaker to this important and unique gathering.
This meeting is a high level, invitee-only event that brings together Burrill & Company’s Limited Partners, such as Bayer CropScience, Celgene, DSM, H.Lundbeck A/S, Kraft Foods, Monsanto, Mitsubishi Corporation, Nestle, Novartis, Procter & ...